News BenevolentAI to power small molecule drug discovery Deal with MRCT will look for potential new drug targets and candidates.
News Google AI detects breast cancer better than pathologists Algorithm achieves a sensitivity rate of 92%.
Views & Analysis Digital Health Round-up - Siemens and Biogen take on MS imag... A round-up of this week's digital healthcare news. Marco Ricci reports.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
